NASDAQ: CURXCuranex Pharmaceuticals Revenue
Curanex Pharmaceuticals revenue was $0.00 for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CURX annual revenue was $0.0, with N/A growth year-over-year.
CURX past revenue growth
How has CURX's revenue growth performed historically?
Company
N/A
Industry
499.16%
Market
37.07%
CURX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CURX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CURX revenue history
Current Revenue
$0.0
Current Earnings
-$4.2M
Current Profit Margin
0%
Be the first to know when CURX announces revenue.
CURX Revenue History By Year
| CURX Yearly Revenue | CURX Revenue | CURX Change | CURX Revenue Growth |
|---|---|---|---|
| 2025-12-31 | $0.00 | N/A | N/A |
| 2024-12-31 | $0.00 | N/A | N/A |
| 2023-12-31 | $0.00 | -$26.00k | -100.00% |
| 2022-12-31 | $26.00k | N/A | N/A |
Curanex Pharmaceuticals Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.